Sox10: A Pan-Schwannian and melanocytic marker

被引:265
作者
Nonaka, Daisuke [1 ]
Chiriboga, Luis
Rubin, Brian P. [2 ]
机构
[1] NYU, Med Ctr, Dept Pathol, Sch Med, New York, NY 10016 USA
[2] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA
关键词
Sox10; S100; protein; neural crest; Schwann cell; melanoma; malignant peripheral nerve sheath tumor;
D O I
10.1097/PAS.0b013e3181658c14
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
S100 protein is a sensitive marker for melanomas and peripheral nerve sheath tumors. It is, however, expressed by other mesenchymal and epithelial tumors. Despite its low specificity. S100 protein is Valuable for the diagnosis of desmoplastic melanomas and peripheral nerve sheath tumors. Cor which no specific marker is available. Sox 10 is a neural crest transcription factor crucial For Specification, Maturation. and maintenance of, Schwann cells and melanocytes. Anti-Sox10 antibody was applied to a variety of neural crest-derived tumors, mesenchymal and epithelial neoplasms, and normal,11 tissues. Sox10 nuclear expression was found in 76 of 78 melanomas (97%) and 38 or 77 malignant peripheral nerve sheath tumors (49%) whereas S100 protein was expressed in 71 melanomas (9 1 %) and 23 malignant peripheral nerve sheath tumors (30%). Sox 10 was diffusely expressed in schwannomas and neurofibromas. Sox10 reaction Was Seen only ill sustentacular Cells Of pheochromocytomas/paragangliomas. and occasionally carcinoid tumors from various organs. but it was not seen in the tumor cells. In norma,11 tissues. Sox 10 was expressed in Schwann cells, melanocytes. and myoepithelial cells of salivary, bronchial. and mammary glands. Sox10 reaction was not identified in any other mesenchymal and epithelial tumors except for myoepitheliomas and diffuse astrocylomas. Sox10 was expressed by metastatic melanomas and nodal capsular nevus in sentinel lymph nodes. but not by other lymph node components Such as dendritic cells. Our results indicate that Sox 10 will serve as a more sensitive and specific marker for the diagnosis of melanocytic and schwannian tumors than S100 protein.
引用
收藏
页码:1291 / 1298
页数:8
相关论文
共 37 条
  • [1] Loss of S100 antigenicity in metastatic melanoma
    Aisner, DL
    Maker, A
    Rosenberg, SA
    Berman, DM
    [J]. HUMAN PATHOLOGY, 2005, 36 (09) : 1016 - 1019
  • [2] [Anonymous], 2000, World Health Organization Classification of Tumors
  • [3] Pathology and Genetics of Tumors of the Digestive System
  • [4] EWS-CREB1:: A recurrent variant fusion in clear cell sarcoma -: Association with gastrointestinal location and absence of melanocytic differentiation
    Antonescu, Cristina R.
    Nafa, Khedoudja
    Segal, Neil H.
    Dal Cin, Paola
    Ladanyi, Marc
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5356 - 5362
  • [5] S-100 PROTEIN NEGATIVE MALIGNANT-MELANOMA - FACT OR FICTION - A LIGHT-MICROSCOPIC AND IMMUNOHISTOCHEMICAL STUDY
    ARGENYI, ZB
    CAIN, C
    BROMLEY, C
    VANNGUYEN, A
    ABRAHAM, AA
    KERSCHMANN, R
    LEBOIT, PE
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1994, 16 (03) : 233 - 240
  • [6] ARGENYI ZB, 2006, PATHOLOGY GENETICS S, P263
  • [7] Banerjee SS, 2000, HISTOPATHOLOGY, V36, P387
  • [8] AN IMMUNOPHENOTYPIC SURVEY OF MALIGNANT MELANOMAS
    BISHOP, PW
    MENASCE, LP
    YATES, AJ
    WIN, NA
    BANERJEE, SS
    [J]. HISTOPATHOLOGY, 1993, 23 (02) : 159 - 166
  • [9] S100-positive spindle cells in scars - A diagnostic pitfall in the re-excision of desmoplastic melanoma
    Chorny, JA
    Barr, RJ
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2002, 24 (04) : 309 - 312
  • [10] IMMUNOHISTOCHEMICAL STUDY OF RHABDOMYOSARCOMA - UNEXPECTED STAINING WITH S100 PROTEIN AND CYTOKERATIN
    COINDRE, JM
    DEMASCAREL, A
    TROJANI, M
    DEMASCAREL, I
    PAGES, A
    [J]. JOURNAL OF PATHOLOGY, 1988, 155 (02) : 127 - 132